AbbVie Inc.ABBV announced a series of regulatory pipeline updates. The company’s Viekirax has been approved by the Japanese Ministry of Health, Labour and Welfare as a new interferon and ribavirin free treatment option for patients suffering from chronic genotype
AbbVie Updates on Viekirax and Rheumatoid Arthritis Pipeline
